How do you manage endocrine therapy for a perimenopausal woman with ER+ breast CA?
The woman was on on a GnRH agonist + AI due to her premenopausal status at diagnosis and now wants to know if she continues to need the GnRH agonist.
1 Answer
Mednet MemberInvited Expert
Medical Oncology · Warren Alpert Medical School of Brown University
Answered on
In lower risk patients to whom I would not routinely give chemotherapy - stage I-IIA, with a low or low-intermediate risk Oncotype score - I start tamoxifen and switch to an aromatase inhibitor (except in very low risk patients in whom the benefit of switching would be negligible) when they are clin...
Join for free or sign in to see the full answer